FDA Drug Application (050718) for DOXIL (LIPOSOMAL) by JANSSEN RES AND DEV

Back to FDA Applications sponsored by JANSSEN RES AND DEV

Application Number050718
Product Number001
FormINJECTABLE, LIPOSOMAL;INJECTION
Dosage20MG/10ML (2MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDOXIL (LIPOSOMAL)
Active IngredientDOXORUBICIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient DOXORUBICIN HYDROCHLORIDE5


Back to FDA Applications sponsored by JANSSEN RES AND DEV